Literature DB >> 29170141

RNA nanoparticle distribution and clearance in the eye after subconjunctival injection with and without thermosensitive hydrogels.

Zhanquan Shi1, S Kevin Li2, Ponwanit Charoenputtakun3, Chia-Yang Liu4, Daniel Jasinski5, Peixuan Guo5.   

Abstract

Thermodynamically and chemically stable RNA nanoparticles derived from the three-way junction (3WJ) of the pRNA from bacteriophage phi29 DNA packaging motor were examined previously for ocular delivery. It was reported that, after subconjunctival injection, RNA nanoparticles with tri-way shape entered the corneal cells but not the retinal cells, whereas particle with four-way shape entered both corneal and retinal cells. The present study evaluated ocular delivery of RNA nanoparticles with various shapes and sizes, and assessed the effect of thermosensitive hydrogels (poly(lactic-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(lactic-co-glycolic acid); PLGA-PEG-PLGA) for increasing the retention of RNA nanoparticles in the eye. Fluorescence imaging of mouse eyes and fluorescence microscopy of dissected eye tissues from the conjunctiva, cornea, retina, and sclera were performed to determine the distribution and clearance of the nanoparticles in the eyes after subconjunctival injection in vivo. RNA nanoparticles entered the cells of the conjunctiva, cornea, retina, and sclera after subconjunctival delivery. The clearance of RNA pentagon was slower than both RNA square and triangle of the same designed edge length (10nm) in the eye, and the clearance of RNA squares of the longer edge lengths (10 and 20nm) was slower than RNA square of the shorter edge length (5nm), thus indicating that the size could affect ocular pharmacokinetics of the nanoparticles. At 24h after the injection, approximately 6-10% of the fluorescence signal from the larger nanoparticles in the study (RNA square of 20nm edge length and RNA pentagon of 10nm edge length) remained in the eye, and up to 70% of the retinal cells contained the nanoparticles. The results suggest that the larger nanoparticles were "gulped" in conjunctival, corneal, retinal, and scleral cells, similar to the behavior observed in macrophages. Additionally, the combination of RNA nanoparticles with the thermosensitive polymers increased the retention of the nanoparticles in the eye.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Double-stranded RNA; Ocular delivery; RNA nanotechnology; Subconjunctival; Temperature sensitive polymer

Mesh:

Substances:

Year:  2017        PMID: 29170141      PMCID: PMC6029979          DOI: 10.1016/j.jconrel.2017.11.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  42 in total

1.  Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration.

Authors:  Aniruddha C Amrite; Uday B Kompella
Journal:  J Pharm Pharmacol       Date:  2005-12       Impact factor: 3.765

Review 2.  Challenges and obstacles of ocular pharmacokinetics and drug delivery.

Authors:  Arto Urtti
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 3.  Strategies for silencing human disease using RNA interference.

Authors:  Daniel H Kim; John J Rossi
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

Review 4.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

5.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

6.  Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.

Authors:  Sridhar Duvvuri; Kumar G Janoria; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2007-06       Impact factor: 2.671

Review 7.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.

Authors:  Eugene W M Ng; David T Shima; Perry Calias; Emmett T Cunningham; David R Guyer; Anthony P Adamis
Journal:  Nat Rev Drug Discov       Date:  2006-02       Impact factor: 84.694

Review 8.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

9.  Ocular surface temperature in age-related macular degeneration.

Authors:  Andrea Sodi; Sara Matteoli; Giovanni Giacomelli; Lucia Finocchio; Andrea Corvi; Ugo Menchini
Journal:  J Ophthalmol       Date:  2014-11-11       Impact factor: 1.909

10.  Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina.

Authors:  Charlotte Andrieu-Soler; Mounia Halhal; Jeffrey H Boatright; Staci A Padove; John M Nickerson; Eva Stodulkova; Rachael E Stewart; Vincent T Ciavatta; Marc Doat; Jean-Claude Jeanny; Therèse de Bizemont; Florian Sennlaub; Yves Courtois; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2007-05-02       Impact factor: 2.367

View more
  9 in total

Review 1.  Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.

Authors:  Sijin Guo; Congcong Xu; Hongran Yin; Jordan Hill; Fengmei Pi; Peixuan Guo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-08-27

Review 2.  The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development.

Authors:  Xin Li; Abhjeet S Bhullar; Daniel W Binzel; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2022-05-05       Impact factor: 17.873

3.  Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice.

Authors:  Chao Wang; Lu Zhang; Jean De La Croix Ndong; Aubryanna Hettinghouse; Guodong Sun; Changhong Chen; Chen Zhang; Ronghan Liu; Chuan-Ju Liu
Journal:  J Neuroinflammation       Date:  2019-11-27       Impact factor: 8.322

Review 4.  Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy.

Authors:  Sean Swetledge; Jangwook P Jung; Renee Carter; Cristina Sabliov
Journal:  J Nanobiotechnology       Date:  2021-01-07       Impact factor: 10.435

Review 5.  Application of Nucleic Acid Frameworks in the Construction of Nanostructures and Cascade Biocatalysts: Recent Progress and Perspective.

Authors:  Gan Zhu; Ping Song; Jing Wu; Minglan Luo; Zhipeng Chen; Tingjian Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-01-07

Review 6.  Nanomaterials based on thermosensitive polymer in biomedical field.

Authors:  Yingshu Guo; Li Sun; Yajing Wang; Qianqian Wang; Dan Jing; Shiwei Liu
Journal:  Front Chem       Date:  2022-09-21       Impact factor: 5.545

Review 7.  Nonviral delivery systems for antisense oligonucleotide therapeutics.

Authors:  Si Huang; Xin-Yan Hao; Yong-Jiang Li; Jun-Yong Wu; Da-Xiong Xiang; Shilin Luo
Journal:  Biomater Res       Date:  2022-09-30

Review 8.  Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology.

Authors:  María L Formica; Hamoudi G Awde Alfonso; Santiago D Palma
Journal:  Pharmacol Res Perspect       Date:  2021-04

9.  Targeted delivery of small noncoding RNA for glioblastoma.

Authors:  Ji Young Yoo; Margaret Yeh; Balveen Kaur; Tae Jin Lee
Journal:  Cancer Lett       Date:  2020-11-08       Impact factor: 8.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.